8-98212477-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001321635.2(NIPAL2):āc.583A>Gā(p.Ile195Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001321635.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NIPAL2 | NM_001321635.2 | c.583A>G | p.Ile195Val | missense_variant | 6/11 | ENST00000430223.7 | NP_001308564.1 | |
NIPAL2-AS1 | XR_928444.3 | n.662+32433T>C | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NIPAL2 | ENST00000430223.7 | c.583A>G | p.Ile195Val | missense_variant | 6/11 | 1 | NM_001321635.2 | ENSP00000407087 | P1 | |
NIPAL2 | ENST00000341166.3 | c.583A>G | p.Ile195Val | missense_variant | 6/12 | 2 | ENSP00000339256 | |||
NIPAL2 | ENST00000520545.5 | n.602A>G | non_coding_transcript_exon_variant | 5/10 | 2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1355950Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 680718
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 30, 2024 | The c.583A>G (p.I195V) alteration is located in exon 6 (coding exon 6) of the NIPAL2 gene. This alteration results from a A to G substitution at nucleotide position 583, causing the isoleucine (I) at amino acid position 195 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.